We serve Chemical Name:3-Amino-3-(4-cyanophenyl)propanoic acid CAS:80971-95-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Amino-3-(4-cyanophenyl)propanoic acid
CAS.NO:80971-95-5
Synonyms:3-Amino-3-(4-cyanophenyl)propanoic acid;3-amino-3-(4-cyanophenyl)propionic acid;aminocyanophenylpropanoicacid;Benzenepropanoic acid, β-amino-4-cyano-;(+/-)-3-amino-3-(4-cyanophenyl)propanoic acid;(R)-3-Amino-3-(4-cyano-phenyl)-propionic acid
Molecular Formula:C10H10N2O2
Molecular Weight:190.199
HS Code:2926909090
Physical and Chemical Properties:
Melting point:226-228ºC(dec)
Boiling point:395.4±37.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.596
PSA:87.11000
Exact Mass:190.074234
LogP:0.35
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Amino-3-(4-cyanophenyl)propanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-3-Amino-3-(4-cyano-phenyl)-propionic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(+/-)-3-amino-3-(4-cyanophenyl)propanoic acid Use and application,(+/-)-3-amino-3-(4-cyanophenyl)propanoic acid technical grade,usp/ep/jp grade.
Related News: From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances). 3-Amino-3-(4-cyanophenyl)propanoic acid manufacturer Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 3-Amino-3-(4-cyanophenyl)propanoic acid supplier All of China��s provinces and territories have now been touched by the outbreak. 3-Amino-3-(4-cyanophenyl)propanoic acid vendor Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 3-Amino-3-(4-cyanophenyl)propanoic acid factory Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.
